BACKGROUND: Human immunodeficiency virus preexposure prophylaxis (PrEP) uptake remains low in high-risk populations. Sexually transmitted infection (STI) clinics reach PrEP-eligible persons and may be ideal settings to model PrEP implementation. METHODS: Consenting PrEP-eligible patients identified at Chicago Department of Public Health STI Clinics were actively referred to PrEP partner sites between June 1, 2015, and May 31, 2016. Outcomes included successful contact by a partner site, linkage to a partner site, and receipt of a PrEP prescription. Bivariable and time to event analyses were conducted to determine significant associations of outcomes. RESULTS: One hundred thirty-seven patients were referred; 126 (92%) were men who have sex with men, and mean age was 29 years. Ninety-eight (72%) were contacted by a PrEP partner, 43 (31%) were linked, and 40 (29%) received a prescription. Individuals aged 25 years and older were more likely to link (odds ratio, 3.10; 95% confidence interval, 1.30-7.41) and receive a PrEP prescription (odds ratio, 2.70; 95% confidence interval, 1.12-6.45) compared with individuals 24 years and younger. The average time between each step was greater for those 24 years and younger compared with those aged 25 years and older for all steps. Time to event analyses revealed that those aged 25 years and older were significantly more likely to receive a prescription compared to those aged 24 years and younger (hazard ratio, 3.62; 95% risk limits, 1.47-8.92). CONCLUSIONS: Preexposure prophylaxis active referrals from STI clinics to partner sites are feasible, though drop out was prominent in the initial steps of the continuum. Youth were less likely to link or receive prescriptions, indicating the need for tailored interventions for this vulnerable population.
BACKGROUND:Human immunodeficiency virus preexposure prophylaxis (PrEP) uptake remains low in high-risk populations. Sexually transmitted infection (STI) clinics reach PrEP-eligible persons and may be ideal settings to model PrEP implementation. METHODS: Consenting PrEP-eligible patients identified at Chicago Department of Public Health STI Clinics were actively referred to PrEP partner sites between June 1, 2015, and May 31, 2016. Outcomes included successful contact by a partner site, linkage to a partner site, and receipt of a PrEP prescription. Bivariable and time to event analyses were conducted to determine significant associations of outcomes. RESULTS: One hundred thirty-seven patients were referred; 126 (92%) were men who have sex with men, and mean age was 29 years. Ninety-eight (72%) were contacted by a PrEP partner, 43 (31%) were linked, and 40 (29%) received a prescription. Individuals aged 25 years and older were more likely to link (odds ratio, 3.10; 95% confidence interval, 1.30-7.41) and receive a PrEP prescription (odds ratio, 2.70; 95% confidence interval, 1.12-6.45) compared with individuals 24 years and younger. The average time between each step was greater for those 24 years and younger compared with those aged 25 years and older for all steps. Time to event analyses revealed that those aged 25 years and older were significantly more likely to receive a prescription compared to those aged 24 years and younger (hazard ratio, 3.62; 95% risk limits, 1.47-8.92). CONCLUSIONS: Preexposure prophylaxis active referrals from STI clinics to partner sites are feasible, though drop out was prominent in the initial steps of the continuum. Youth were less likely to link or receive prescriptions, indicating the need for tailored interventions for this vulnerable population.
Authors: Chen Zhang; James McMahon; Kevin Fiscella; Sarahmona Przybyla; Amy Braksmajer; Natalie LeBlanc; Yu Liu Journal: AIDS Patient Care STDS Date: 2019-12 Impact factor: 5.078
Authors: Jessica P Ridgway; Ellen A Almirol; Alvie Bender; Andrew Richardson; Jessica Schmitt; Eleanor Friedman; Nicola Lancki; Ivan Leroux; Nina Pieroni; Jessica Dehlin; John A Schneider Journal: AIDS Patient Care STDS Date: 2018-04-19 Impact factor: 5.078
Authors: Rebecca Spicehandler; Jason Zucker; Caitlin Yumori; Matthew Adan; Caroline Carnevale; Deborah Theodore; Delivette Castor; Kathrine Meyers; Susan Whittier; Michael T Yin; Alwyn Cohall; Susan Olender; Peter Gordon; Magdalena E Sobieszczyk Journal: Sex Transm Dis Date: 2022-07-29 Impact factor: 3.868
Authors: Rebecca Lillis; Jeremy Beckford; Joshua Fegley; Julia Siren; Bruce Hinton; Samuel Gomez; Stephanie N Taylor; Isolde Butler; Jason Halperin; Meredith Edwards Clement Journal: AIDS Patient Care STDS Date: 2021-08-26 Impact factor: 5.944
Authors: Aditya S Khanna; John A Schneider; Nicholson Collier; Jonathan Ozik; Rodal Issema; Angela di Paola; Abigail Skwara; Arthi Ramachandran; Jeannette Webb; Russell Brewer; William Cunningham; Charles Hilliard; Santhoshini Ramani; Kayo Fujimoto; Nina Harawa Journal: AIDS Date: 2019-10-01 Impact factor: 4.177
Authors: Rupa R Patel; Amy S Nunn; Kenneth H Mayer; Timothy McBride; Ross C Brownson; Cheryl Oliver; Maria M Perez; Laura C Harrison; Amber Salter; John S Crane; Philip A Chan Journal: AIDS Patient Care STDS Date: 2019-01-16 Impact factor: 5.944
Authors: M Bryant Howren; Shelby L Francis; Linnea A Polgreen; Cody Shafer; Angela Hoth; Michael E Ohl Journal: Public Health Rep Date: 2020-10-27 Impact factor: 2.792